Template:Dgfn2015 So xx:00 Molekulare Methoden, neuere

From HOP house of papers
(Difference between revisions)
Jump to: navigation, search
m
m
 
(2 intermediate revisions by one user not shown)
Line 1: Line 1:
==CRISPR/Cas9 – ein Quantensprung in der Gentechnik==
+
==So 08:45 Molekulare Methoden, neuere==
 +
 
 +
===CRISPR/Cas9 – ein Quantensprung in der Gentechnik===
 
[http://nephrologie.conference2web.com/users/7523 Schermer-B]
 
[http://nephrologie.conference2web.com/users/7523 Schermer-B]
 
{{tp|p=22745249|t=2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity |pdf=http://diyhpl.us/~bryan/papers2/paperbot/A%20Programmable%20Dual-RNAGuided%20DNA%20Endonuclease%20in%20Adaptive%20Bacterial%20Immunity.pdf|usr=|c=First description of the cc system}}
 
{{tp|p=22745249|t=2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity |pdf=http://diyhpl.us/~bryan/papers2/paperbot/A%20Programmable%20Dual-RNAGuided%20DNA%20Endonuclease%20in%20Adaptive%20Bacterial%20Immunity.pdf|usr=|c=First description of the cc system}}
Line 9: Line 11:
 
{{utp|p=25908821|t=2015. Genome editing  The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations |pdf=http://www.sciencemag.org/content/348/6233/442.long|usr=}}
 
{{utp|p=25908821|t=2015. Genome editing  The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations |pdf=http://www.sciencemag.org/content/348/6233/442.long|usr=}}
  
==miRNA als diagnostisches Werkzeug im klinischen Alltag?==
+
===miRNA als diagnostisches Werkzeug im klinischen Alltag?===
 
[http://nephrologie.conference2web.com/users/7525 Lorenzen JM]
 
[http://nephrologie.conference2web.com/users/7525 Lorenzen JM]
 +
 +
{{tp|p=18455518|t=2008. Lysophosphatidic acid and renal fibrosis |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=18455518&pmc=2577601&ti=Lysophosphatidic%20acid%20and%20renal%20fibrosis|usr=}}
 
{{utp|p=21423249|t=2011. MicroRNAs as mediators and therapeutic targets in chronic kidney disease |pdf=http://www.nature.com/nrneph/journal/v7/n5/full/nrneph.2011.26.html|usr=}}
 
{{utp|p=21423249|t=2011. MicroRNAs as mediators and therapeutic targets in chronic kidney disease |pdf=http://www.nature.com/nrneph/journal/v7/n5/full/nrneph.2011.26.html|usr=}}
 
{{utp|p=16258535|t=2005. Silencing of microRNAs in vivo with  antagomirs  |pdf=http://www.nature.com/nature/journal/v438/n7068/full/nature04303.html|usr=}}
 
{{utp|p=16258535|t=2005. Silencing of microRNAs in vivo with  antagomirs  |pdf=http://www.nature.com/nature/journal/v438/n7068/full/nature04303.html|usr=}}
Line 24: Line 28:
 
{{tp|p=22715378|t=2012. Circulating microRNAs are not eliminated by hemodialysis |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=22715378&pmc=3371001&ti=Circulating%20microRNAs%20are%20not%20eliminated%20by%20hemodialysis|usr=}}
 
{{tp|p=22715378|t=2012. Circulating microRNAs are not eliminated by hemodialysis |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=22715378&pmc=3371001&ti=Circulating%20microRNAs%20are%20not%20eliminated%20by%20hemodialysis|usr=}}
  
==Translation of anti-fibrotic microRNA strategies into a mouse model of chronic allograft dysfunction==
+
===Translation of anti-fibrotic microRNA strategies into a mouse model of chronic allograft dysfunction===
 
[http://nephrologie.conference2web.com/users/7524 Schauerte C]
 
[http://nephrologie.conference2web.com/users/7524 Schauerte C]
 
{{tp|p=18455518|t=2008. Lysophosphatidic acid and renal fibrosis |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=18455518&pmc=2577601&ti=Lysophosphatidic%20acid%20and%20renal%20fibrosis|usr=}}
 
{{tp|p=18455518|t=2008. Lysophosphatidic acid and renal fibrosis |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=18455518&pmc=2577601&ti=Lysophosphatidic%20acid%20and%20renal%20fibrosis|usr=}}
Line 30: Line 34:
 
{{tp|p=23131772|t=2012. MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=23131772&pmc=3541003&ti=MicroRNA%20sequence%20profiles%20of%20human%20kidney%20allografts%20with%20or%20without%20tubulointerstitial%20fibrosis|usr=}}
 
{{tp|p=23131772|t=2012. MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=23131772&pmc=3541003&ti=MicroRNA%20sequence%20profiles%20of%20human%20kidney%20allografts%20with%20or%20without%20tubulointerstitial%20fibrosis|usr=}}
  
==Funktionelle Proteom-Analysen in der Nephrologie==
+
===Funktionelle Proteom-Analysen in der Nephrologie===
 
[http://nephrologie.conference2web.com/users/7526 Rinschen M]
 
[http://nephrologie.conference2web.com/users/7526 Rinschen M]
 
webcast not available
 
webcast not available
Line 40: Line 44:
 
{{tp|p=20713729|t=2010. Quantitative phosphoproteomic analysis reveals cAMP/vasopressin-dependent signaling pathways in native renal thick ascending limb cells |pdf=http://www.pnas.org/content/107/35/15653.full.pdf|usr=}}
 
{{tp|p=20713729|t=2010. Quantitative phosphoproteomic analysis reveals cAMP/vasopressin-dependent signaling pathways in native renal thick ascending limb cells |pdf=http://www.pnas.org/content/107/35/15653.full.pdf|usr=}}
 
{{tp|p=24511133|t=2014. Phosphoproteomic analysis reveals regulatory mechanisms at the kidney filtration  barrier |pdf=http://jasn.asnjournals.org/content/25/7/1509.full.pdf|usr=}}
 
{{tp|p=24511133|t=2014. Phosphoproteomic analysis reveals regulatory mechanisms at the kidney filtration  barrier |pdf=http://jasn.asnjournals.org/content/25/7/1509.full.pdf|usr=}}
{{tp|p=25420462|t=2015. Comparative phosphoproteomic analysis of mammalian glomeruli reveals conserved podocin C-terminal phosphorylation as a determinant of slit diaphragm complex architecture |pdf=http://onlinelibrary.wiley.com/doi/10.1002/pmic.201400235/epdf|usr=}}
+
{{utp|p=25420462|t=2015. Comparative phosphoproteomic analysis of mammalian glomeruli reveals conserved podocin C-terminal phosphorylation as a determinant of slit diaphragm complex architecture |pdf=http://onlinelibrary.wiley.com/doi/10.1002/pmic.201400235/epdf|usr=}}
 
+
{{tp|p=23438854|t=2013. The coming age of complete, accurate, and ubiquitous proteomes |pdf=http://www.cell.com/molecular-cell/pdf/S1097-2765(13)00093-2.pdf|usr=}}
 
+
{{tp|p=23201125|t=2013. A map of general and specialized chromatin readers in mouse tissues generated by  label-free interaction proteomics |pdf=http://www.cell.com/molecular-cell/pdf/S1097-2765(12)00907-0.pdf|usr=}}
 
+
{{tp|p=24573087|t=2014. Label-free quantitative proteomic analysis of the YAP/TAZ interactome |pdf=http://ajpcell.physiology.org/content/ajpcell/306/9/C805.full.pdf|usr=}}
 
+
{{utp|p=24051958|t=2013. Large-scale identification of ubiquitination sites by mass spectrometry |pdf=http://www.nature.com/nprot/journal/v8/n10/full/nprot.2013.120.html|usr=}}
 
+
 
+
 
+
 
+
{{tp|p=18455518|t=2008. Lysophosphatidic acid and renal fibrosis |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=18455518&pmc=2577601&ti=Lysophosphatidic%20acid%20and%20renal%20fibrosis|usr=}}
+

Latest revision as of 06:44, 22 September 2015

Contents

So 08:45 Molekulare Methoden, neuere

CRISPR/Cas9 – ein Quantensprung in der Gentechnik

Schermer-B

Journal article, free access (Hinweis: First description of the cc system)
GET 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity Extract PDF direct
Journal article, free access
GET 2013. Genome engineering using the CRISPR-Cas9 system Extract PDF direct
Journal article, free access
GET 2013. Genome engineering using the CRISPR-Cas9 system Extract PDF direct
Journal article, free access (Hinweis: Major bioethical document)
GET 2015. CRISPR, the disruptor Extract PDF direct
Journal article, free access
GET 2015. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes Extract PDF direct
Journal Paper, restricted access
GET 2015. BIOSAFETY Safeguarding gene drive experiments in the laboratory Extract PDF direct
Journal Paper, restricted access
GET 2015. Genome editing The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations Extract PDF direct

miRNA als diagnostisches Werkzeug im klinischen Alltag?

Lorenzen JM

Journal article, free access
GET 2008. Lysophosphatidic acid and renal fibrosis Extract PDF direct
Journal Paper, restricted access
GET 2011. MicroRNAs as mediators and therapeutic targets in chronic kidney disease Extract PDF direct
Journal Paper, restricted access
GET 2005. Silencing of microRNAs in vivo with antagomirs Extract PDF direct
Journal article, free access
GET 2009. MicroRNA expression profiles predictive of human renal allograft status Extract PDF direct
Journal article, free access
GET 2012. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways Extract PDF direct
Journal article, free access
GET 2014. MicroRNA-24 antagonism prevents renal ischemia reperfusion injury Extract PDF direct
Journal article, free access
GET 2012. Circulating and urinary microRNAs in kidney disease Extract PDF direct
Journal article, free access
GET 2014. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy Extract PDF direct
Journal article, free access
GET 2011. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma Extract PDF direct
Journal article, free access
GET 2011. Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients Extract PDF direct
Journal article, free access
GET 2012. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells Extract PDF direct
Journal article, free access
GET 2011. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury Extract PDF direct
Journal article, free access
GET 2012. Circulating microRNAs are not eliminated by hemodialysis Extract PDF direct

Translation of anti-fibrotic microRNA strategies into a mouse model of chronic allograft dysfunction

Schauerte C

Journal article, free access
GET 2008. Lysophosphatidic acid and renal fibrosis Extract PDF direct

?? ncb 2009...

Journal article, free access
GET 2012. MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis Extract PDF direct

Funktionelle Proteom-Analysen in der Nephrologie

Rinschen M webcast not available

?2014 nature au? ?2010 ncb coudhary/choudhary?

Journal article, free access
GET 2006. Quantitative phosphoproteomics of vasopressin-sensitive renal cells: regulation of aquaporin-2 phosphorylation at two sites Extract PDF direct
Journal article, free access
GET 2010. Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor-dependent signaling pathways in renal collecting duct cells Extract PDF direct
Journal article, free access
GET 2010. Quantitative phosphoproteomic analysis reveals cAMP/vasopressin-dependent signaling pathways in native renal thick ascending limb cells Extract PDF direct
Journal article, free access
GET 2014. Phosphoproteomic analysis reveals regulatory mechanisms at the kidney filtration barrier Extract PDF direct
Journal Paper, restricted access
GET 2015. Comparative phosphoproteomic analysis of mammalian glomeruli reveals conserved podocin C-terminal phosphorylation as a determinant of slit diaphragm complex architecture Extract PDF direct
Journal article, free access
GET 2013. The coming age of complete, accurate, and ubiquitous proteomes Extract PDF direct
Journal article, free access
GET 2013. A map of general and specialized chromatin readers in mouse tissues generated by label-free interaction proteomics Extract PDF direct
Journal article, free access
GET 2014. Label-free quantitative proteomic analysis of the YAP/TAZ interactome Extract PDF direct
Journal Paper, restricted access
GET 2013. Large-scale identification of ubiquitination sites by mass spectrometry Extract PDF direct
Personal tools
Namespaces
Variants
Actions
Navigation
Toolbox
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis